DGPDHGCN: A Heterogeneous Graph Convolutional Network Method for Predicting Drug-Disease Associations

Drug repositioning is a crucial aspect of biomedical research, and predicting drug-disease associations (DDAs) is a critical step in this process. With the development of deep learning and neural network technologies, Graph Convolutional Networks (GCNs) have achieved significant performances in this research field. Although existing DDAs models have made substantial progress, there is still need for improvement in sufficiently utilizing and integrating information from multiple biological entities. In this study, we propose a Drug-Gene-Protein-Disease Heterogeneous Graph Convolutional Network (DGPDHGCN) model for drug-disease association prediction. First, we construct a heterogeneous network from multiple data sources and establish meta-paths based on the topological information of biological entities. Then, the DGPDHGCN model learns representations of drugs and diseases from similarity and association data of those entities. Finally, we define a score function to quantify the associations between drugs and diseases. Through extensive experiments, we demonstrate that DGPDHGCN outperforms baseline models in DDAs prediction tasks in terms of metrics such as AUPR, F1-score, precision, and recall. The source code and experimental datasets can be found in https://github.com/Saxon0918/DGPDHGCN

Authors

Institutions

Publication Details

Published
2024-12-03
DOI
https://doi.org/10.1109/bibm62325.2024.10822493
Citations
3
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
1.08
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

DGPDHGCN: A Heterogeneous Graph Convolutional Network Method for Predicting Drug-Disease Associations

Tong Yu, Jianjia Wang, Haoran Zhu, Ling Ge
3 citations
Computational Drug Discovery Methods
1.08
article

DGPDHGCN: A Heterogeneous Graph Convolutional Network Method for Predicting Drug-Disease Associations

Tong Yu, Jianjia Wang, Haoran Zhu, Ling Ge
article en
3 citations

Abstract

Drug repositioning is a crucial aspect of biomedical research, and predicting drug-disease associations (DDAs) is a critical step in this process. With the development of deep learning and neural network technologies, Graph Convolutional Networks (GCNs) have achieved significant performances in this research field. Although existing DDAs models have made substantial progress, there is still need for improvement in sufficiently utilizing and integrating information from multiple biological entities. In this study, we propose a Drug-Gene-Protein-Disease Heterogeneous Graph Convolutional Network (DGPDHGCN) model for drug-disease association prediction. First, we construct a heterogeneous network from multiple data sources and establish meta-paths based on the topological information of biological entities. Then, the DGPDHGCN model learns representations of drugs and diseases from similarity and association data of those entities. Finally, we define a score function to quantify the associations between drugs and diseases. Through extensive experiments, we demonstrate that DGPDHGCN outperforms baseline models in DDAs prediction tasks in terms of metrics such as AUPR, F1-score, precision, and recall. The source code and experimental datasets can be found in https://github.com/Saxon0918/DGPDHGCN

Shanghai University of Engineering Science (CN), Xi’an Jiaotong-Liverpool University (CN)
Openalex Percentile: Top 19%
Computational Drug Discovery Methods
1.08
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.